”After years of research we suddenly realised how to combine our findings. It was a eureka moment.”

Introducing Amferia wound dressing for animal care — binds and kills bacteria without harming the body

How antimicrobial hydrogel can revolutionize clinical treatments

Binds and kills 99.99% of bacteria without harming the body – even resistant bacteria

Introducing Amferia wound dressing for animal care — binds and kills bacteria without harming the body

Antimicrobial dressing:

Amferia has invented a new antimicrobial hydrogel that  targets, binds, and rapidly kills upto 99.99% of bacteria upon contact. The hydrogel consists of amphiphilic antibacterial polymers mimicking the immune system. This makes it completely safe for the body and the hydrogel does not release anything into the wound.

Amferia is producing a veterinary antimicrobial hydrogel wound dressing, expected to be introduced in late 2022, available for pre-orders now.

Appropriate for acute and low exuding wounds, like post-surgical incisions, this product can be used as a free-standing hydrogel pad supported on the wound by a secondary dressing, or as a fully adhesive dressing.

Meant exclusively for veterinary in-clinic use, like surgical care units or in-patient care, all products are supplied sterile and will include instructions for use.  

Read more about the science behind Amferia's products >

Amferia non-adhesive hydrogel dressing

Product description:

Our free-standing hydrogel dressing is currently available for purchase in three standard sizes. The pad is non-adhesive sheet of hydrogel that can be applied directly to a wound bed.

The dressing is non-adhesive to wound and requires secondary surgical-grade dressing to hold it in place, which Amferia will provide with shipment. Alternatively, customers can use a secondary dressing of their choice. We may also be able to provide custom sizes of the hydrogel pad upon request.

Please contact us with your request >

Easily adaptable to wound, custom sizes can be ordered, can be used with transparent film or absorbent dressings.

  • Hydrogel sizes and product article numbers
  • 1. 4 x 7.5 cm —10085475
  • 2. 4 x 15 cm — 10085415
  • 3. 5 x 20 cm — 10085520
  • We may also be able to provide custom sizes of the hydrogel dressing upon request.

Product Video — How to use the Amferia non-adhesive hydrogel dressing

Amferia adhesive hydrogel dressing

Coming product:

The adhesive hydrogel dressing will be available for purchase from 2023. At present, we offer the adhesive dressings on a trial basis for case feedback on dry to low exuding wounds. We are interested to collaborate with clinics interested to try the products or discus clinical investigations.

Please contact us to discuss further or request a product specification document >

Evidence of safety and efficacy in post-surgical wounds

Case studies:

Amferia has collaborated with five leading veterinary clinics across Europe and performed over 100 case studies on a variety of post-surgical wounds of cats and dogs.

Amferia’s hydrogel dressing enabled safe healing of the wound with no complications. Furthermore, the product could be adapted easily to the complex contours of the animal’s body and adjusted to the required size.

The surgeons who used the dressings have provided excellent feedback on the usability, safety and the existing evidence on antimicrobial efficacy.

Infected wounds — killing multi-resistant bacteria

Chronic wounds:

Case studies involving Amferia hydrogel dressings have been performed on infected chronic wounds in collaboration with two clinics in Germany and the Netherlands.

Together with Amferia, the clinics have performed six case evaluations of the Amferia hydrogel dressing in hard-to-heal infected wounds of one dog and five cats, all colonized with multi-resistant pseudomonas aeuruginosa or MRSA bacteria. 

All wounds were open wounds from either trauma or chronic complications, and the patients suffered from recurring wound complications over a period of two to three months. The attending wound specialist requested Amferia dressing for trials on the patients and noted a clear effect within 24 hours, noting bio-burden reduction and formulation of new granulation tissue.

100 times reduction of bacterial load in deep infected wounds

In-vivo study:

Amferia collaborated on an in-vivo infection model study with Chalmers University and the Department of Biomaterials at Sahlgrenska University. 

The study results published in ACS Biomaterials Science, was a wound model in mice heavily infected with bacteria. The results demonstrated 100 times reduction of bacterial load in the wounds treated with the amphiphilic antimicrobial hydrogel.  

This is especially impressive, given that the wound was deep and the bacterial load was extremely high. The results demonstrated the strong effect the hydrogels had on bacterial removal, solely upon contact and without releasing any substances, from the wound in a statistically significant manner. 

Feedback

What clinicians say:

  • "It was very easy and fits very well"
  • Dr Christian Ness, Anicura Weingarten
  • "We are very pleased with your product. Can we get an offer?”
  • Dr Ulrich Schmidt, Veterinary clinic Wandsbek
  • "Granulation tissue observed and visible change in bioburden"
  • Dr Peter Engelhardt, Anicura Haan, Germany

How to buy Amferia’s hydrogel wound dressing

Order now:

Amferia Antimicrobial Hydrogel Dressing is available for purchase in Sweden through our distributor, Triolab AB.

The currently available product for purchase is the free-standing hydrogel dressing, provided in 3 standard sizes. A sheet of hydrogel that can be applied directly to the wound bed and is non-adhesive to wound.

Please contact our Sales Director Saba Atefyekta (PhD) for ordering information >

Collaborate with us and receive samples for trials. Amferia is happy to provide samples of our current and upcoming products for early trials for post-surgical and other dry-to-low exuding wound applications.

Please contact our Product Manager Rojan Modaresi (DVM, PhD) with your interest for product trials >

Amferia presents at Brilliant Minds conference 2019, Stockholm

June 15, 2019

Amferia was honoured to pitch as one of the ‘Next Brilliant in Tech‘ at Brilliant Minds 2019 held at Stockholm between 13-15 June. With esteemed guests like President Barack Obama, Secretary John Kerry, Greta Thunberg, the conference was an enlightening and inspiring event with much hope for the future.

The Recent UN Report on Antibiotic Resistance

May 3, 2019

The United Nations appointed Interagency Coordination Group on Antimicrobial Resistance (IACG) has presented its report on Recommendations to Combat Antimicrobial Resistance (AMR). It is clear from the report that AMR is a global and complex threat that needs to be addressed with extreme urgency and with care. Consistent, coordinated and conscious actions are demanded, especially from the World Goverments, Academia, Public, Healthcare-Industry and  Agriculture. A world where bacterial infections cannot be fought efficiently is a world of perils.

Here is an excerpt from the IACG report.

“The challenges of antimicrobial resistance are complex and multifaceted, but they are not insurmountable. Implementation of the recommendations in this report will help to save millions of lives, preserve antimicrobials for generations to come and secure the future from drug-resistant diseases.

But there is no time to wait.”

-IACG Report, April 29, 2019

Do take a minute and read the summary of this important report (English, pdf 653 kb)

Amferia featured in Göteborgs-Posten

February 8, 2019

New patch from Gothenburg kills bacteria in wounds. Read to know more

Amferia wins the Swedbank Rivstart 2018

February 7, 2019

Amferia is proud to become the winners of the annual entrepreneur competition hosted by Swedbank, Rivstart. From over 1825 applications, Amferia finished on top!

Amferia wins the Venture Day 2018, hosted by Chalmers Ventures

November 28, 2018

Amferia is proud to be named winners of the annual Pitch competition hosted by Chalmers Ventures.